Up First briefing: Trump won't testify; FDA approves landmark gene-editing treatment

Donald Trump plans to skip testifying for a second time in the New York civil fraud trial. The FDA has approved the first-ever gene-editing treatment for a human disease.

By: NPR

Jan 11 2024
11
249 Views

Good morning. You're reading the Up First newsletter. Subscribe here to get it delivered to your inbox, and listen to the Up First podcast for all the news you need to start your day. Today's top st… [+5247 chars]

Broadway audiences are getting a little bit younger and more diverse

Actor Jonathan Majors receives mixed verdict in criminal domestic violence trial

New York City to utilize 8,500 acres of parking lots for incredible new initiative: ‘A bold step forward’

OpenAI se planta contra ‘The New York Times’ y lo acusa de «manipular» a ChatGPT

New York Appeals Court Orders Legislature To Draw New Congressional Districts

Bird files for bankruptcy after going public in 2021

It takes 30 minutes for a SiriusXM customer to unsubscribe — too long, New York state says. It's suing.

Take a look inside the biggest-ever office building to be transformed into homes in New York City

Former Trump ‘fixer’ Michael Cohen admits using Google Bard to cite bogus court cases

New York Mayor Eric Adams gives bizarre answer to a simple question

New York Times sues OpenAI and Microsoft, claiming copyright infringement

Sabbath showdown: Chick-fil-A vs. New York State legislation

Share this page

Guest Posts by Easy Branches

Premium Escort Website Platform: The Perfect Blend

Nourishing the Mind: The Role of Nutrition and Exe

Introducing AI and Machine Learning to Kids

all our websites